Buetow, Stephen A
Martínez-Martín, Pablo
Hirsch, Mark A
Okun, Michael S
Article History
Received: 22 February 2016
Revised: 20 July 2016
Accepted: 23 August 2016
First Online: 22 September 2016
Competing interests
: PM-M is an Associate Editor of npj Parkinsons Disease—Nature. PM-M received an honorarium from Editorial Viguera for a Masters-level course and from AbbVie for participating as a member of the Advisory Board for an epidemiological study. PM-M has also received a grant from the International Parkinson and Movement Disorder Society for the Pilot Study of the MDS-Non-Motor Symptoms Scale. MSO serves as a consultant for the National Parkinson Foundation, and has received research grants from NIH, NPF, the Michael J. Fox Foundation, the Parkinson Alliance, Smallwood Foundation, the Bachmann-Strauss Foundation, the Tourette Syndrome Association, and the UF Foundation. MSO has previously received honoraria, but in the past >60 months has received no support from industry. MSO has received royalties for publications with Demos, Manson, Amazon, Smashwords, Books4Patients, and Cambridge (movement disorders books). MSO is an Associate Editor for New England Journal of Medicine Journal Watch Neurology. MSO has participated in CME and educational activities on movement disorders (in the last 36) months sponsored by PeerView, Prime, QuantiaMD, WebMD, MedNet, Henry Stewart, and by Vanderbilt University. The institution and not MSO receives grants from Medtronic, Abbvie, Allergan, and ANS/St Jude, and the principal investigator (PI) has no financial interest in these grants. MSO has participated as a site PI and/or co-I for several NIH, foundation, and industry sponsored trials over the years but has not received honoraria. MAH has served on the editorial board of Parkinsonism and Related Disorders, presently serves on the editorial board of Topics in Geriatric Rehabilitation, has received travel honoraria from both the International Association of Parkinsonism and Related Disorders and the World Confederation of Physical Therapy, and has been the PI on grants from NIH (NICHD), Park Foundation, and Duke Endowment. The remaining author declares no conflict of interest.